chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Vaccination site pain, Vulvovaginal pruritus
Clinical narrative: sore arm at injection site; burning at arm pit; Vaginal itching; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A female patient received bnt162b2 (COMIRNATY), administration date Oct2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "sore arm at injection site"; BURNING SENSATION (non-serious) with onset 2021, outcome "recovered", described as "burning at arm pit"; VULVOVAGINAL PRURITUS (non-serious) with onset 2021, outcome "unknown", described as "Vaginal itching".  Additional Information: Patient got the first dose two weeks ago yesterday.  Follow-up attempts are completed. No further information is expected. The lot/batch number is not available despite the follow-up attempts made.
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Rash, Rash pruritic
Clinical narrative: Two days ago she got a rash around the injection site; now it is all the way down to her elbow; her neck is so bad and so itchy that she could just scratch all the skin off; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 02Nov2021 (Lot number: FF2593, Expiration Date: 02Nov2021) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for COVID-19 immunization; Bnt162b2 (2nd dose), for COVID-19 immunization. The following information was reported: INJECTION SITE RASH (non-serious) with onset 06Nov2021, outcome "unknown", described as "Two days ago she got a rash around the injection site"; RASH (non-serious) with onset 06Nov2021, outcome "unknown", described as "now it is all the way down to her elbow"; RASH PRURITIC (non-serious) with onset 06Nov2021, outcome "unknown", described as "her neck is so bad and so itchy that she could just scratch all the skin off".  Additional information: Is report related to a study or programme: Yes. "I have a consumer on the line. So, she got a booster dose of the Pfizer vaccine six days ago, two days ago she got a rash around the injection site and now it is all the way down to her elbow and her neck is so bad and so itchy that she could just scratch all the skin off. So, when you done talking with her can you please get her over to medical." "She just wants to know if it is a normal thing or not and if it is from the vaccine."  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Cough, Malaise, Nasopharyngitis, Rhinorrhoea
Clinical narrative: cough; cold-symptoms; runny nose; ill; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A male patient received bnt162b2 (COMIRNATY), administration date 07Oct2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COUGH (non-serious) with onset 2021, outcome "unknown", described as "cough"; NASOPHARYNGITIS (non-serious) with onset 2021, outcome "not recovered", described as "cold-symptoms"; RHINORRHOEA (non-serious) with onset 2021, outcome "unknown", described as "runny nose"; MALAISE (non-serious) with onset 2021, outcome "unknown", described as "ill".  Additional information: Male patient received primary first shot on 07Oct2021, he is feeling ill as far as cold symptoms, runny nose, cough no fever, now on day 33 past first dose, would Pfizer still recommend giving the shot with cold symptoms?. Is there any efficacy data on the first shot?  The Lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: she started having numbness and tingling in her arm; she started having numbness and tingling in her arm; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) for a Pfizer sponsored program.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious), outcome "not recovered" and all described as "she started having numbness and tingling in her arm".  Additional information: No patient identifier were provided but the reporter has first hand knowledge of the patient and was reporting on a specific patient. Pharmacist has a patient who received the Covid vaccine and a few days after receiving it she started having numbness and tingling in her arm and it has been going on for a week now. Wondering how long this may last.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Discomfort, Pruritus, Rash
Clinical narrative: broke out in a rash, described as red dots; little blisters all over her body; It was very uncomfortable and itchy but it was all over her body; It was very uncomfortable and itchy but it was all over her body; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 78 year-old female patient received bnt162b2 (COMIRNATY), administration date 23Aug2021 (Batch/Lot number: unknown) at the age of 78 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1,SINGLE, Exp.dt- May2021, Lot/Batch number-EN5318), administration date: 04Feb2021, for COVID-19 immunization; Bnt162b2 (DOSE 2,SINGLE, Exp.dt- 30Jun2021, Lot/Batch number: EN6202), administration date: 25Feb2021, for COVID-19 immunization. The following information was reported: RASH (non-serious) with onset 23Sep2021, outcome "recovering", described as "broke out in a rash, described as red dots"; BLISTER (non-serious) with onset 23Sep2021, outcome "recovering", described as "little blisters all over her body"; DISCOMFORT (non-serious), PRURITUS (non-serious) all with onset 23Sep2021, outcome "recovering" and all described as "It was very uncomfortable and itchy but it was all over her body".  Additional info: Patient went through one course of treatment that did not work and it had to do with. The 2nd course was working. She asked dermatologist. She could not think of the name, it was prednisone and an anti-inflammatory, in case it was an allergic reaction but it didn't work. She then went to a dermatologist who told her to treat it with a steroid ointment, which she had been using and it had somewhat minimized the outbreak after two weeks of use and she was going to use it for one more week.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Follow-up (13Dec2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Asthenia, Taste disorder
Clinical narrative: Had both doses no energy; Food has no taste; Taste like perfume; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 74 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ASTHENIA (non-serious), outcome "unknown", described as "Had both doses no energy"; AGEUSIA (non-serious), outcome "unknown", described as "Food has no taste"; TASTE DISORDER (non-serious), outcome "unknown", described as "Taste like perfume".  Additional information: The patient was to receive booster that day with a friend.  She states she was feeling under the weather and asking if she should take it? She states she has had both doses no energy for the past few weeks. Food has no taste. Taste like perfume.    The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Malaise, Taste disorder
Clinical narrative: Had both doses no energy; Food has no taste; Taste like perfume; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 74 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ASTHENIA (non-serious), outcome "unknown", described as "Had both doses no energy"; AGEUSIA (non-serious), outcome "unknown", described as "Food has no taste"; TASTE DISORDER (non-serious), outcome "unknown", described as "Taste like perfume".  Additional information: The patient was to receive booster that day with a friend.  She states she was feeling under the weather and asking if she should take it? She states she has had both doses no energy for the past few weeks. Food has no taste. Taste like perfume.    The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pruritus, Pyrexia
Clinical narrative: itches; chills; fever; aches; I have a rash where the injection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Nov2021 17:30 (Lot number: FG3527) at the age of 45 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: ALLEGRA D. The following information was reported: PRURITUS (non-serious) with onset 04Nov2021, outcome "recovering", described as "itches"; CHILLS (non-serious) with onset 04Nov2021, outcome "recovering", described as "chills"; PYREXIA (non-serious) with onset 04Nov2021, outcome "recovering", described as "fever"; PAIN (non-serious) with onset 04Nov2021, outcome "recovering", described as "aches"; VACCINATION SITE RASH (non-serious) with onset 04Nov2021, outcome "recovering", described as "I have a rash where the injection". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pruritus, chills, pyrexia, pain, vaccination site rash.  Additional Information: The patient did not received any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. adverse event: I had chills fever aches all the night after I had shot I have a rash where the injection was and it itches and is hard to touch  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: itches; chills; fever; aches; I have a rash where the injection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Nov2021 17:30 (Lot number: FG3527) at the age of 45 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: ALLEGRA D. The following information was reported: PRURITUS (non-serious) with onset 04Nov2021, outcome "recovering", described as "itches"; CHILLS (non-serious) with onset 04Nov2021, outcome "recovering", described as "chills"; PYREXIA (non-serious) with onset 04Nov2021, outcome "recovering", described as "fever"; PAIN (non-serious) with onset 04Nov2021, outcome "recovering", described as "aches"; VACCINATION SITE RASH (non-serious) with onset 04Nov2021, outcome "recovering", described as "I have a rash where the injection". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pruritus, chills, pyrexia, pain, vaccination site rash.  Additional Information: The patient did not received any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. adverse event: I had chills fever aches all the night after I had shot I have a rash where the injection was and it itches and is hard to touch  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal
Clinical narrative: she felt blah for half a day; She was tired with the second one; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Apr2021 (Lot number: EW0161) at the age of 37 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose,  lot number: ER8734, Anatomical Location: Left arm), administration date: 31Mar2021, when the patient was 37 years old, for COVID-19 Immunization, reaction(s): "pectoralis minor muscle that runs from arm pit to chest was so tense". The following information was reported: FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "She was tired with the second one"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "she felt blah for half a day".  Additional information:  Patient had a weird thing happen after the first one. patient teaches dance and pole dance requires upper body strength and arm strength. She taught a dance class the night she got her vaccine. It stretched her arms out. At one point, she is strong willed, she was not sure if it was in her head. The pectoralis minor muscle that runs from arm pit to chest was so tense and she couldn't get it to relax. She went to urgent care and they gave her a muscle relaxer. Caller thinks it was more of a life style issue instead of a vaccine issue. She knows she shouldn't have done dance the same day as the vaccine. After the second one she felt blah for half a day, but not bad at all. She was tired with the second one. It was a good reason for a nap. Caller clarified product she received as Pfizer COVID Vaccine. Patient states it is the good one.   No follow-up attempts are possible. No further information is expected.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 10 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 08Nov2021 (Lot number: Ff2590) at the age of 10 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU taken for immunisation, administration date 11Oct2021. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 09Nov2021, outcome "recovered", described as "Sore arm". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has  not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: His arm was extremely sore after booster; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for Covid-19 Immunization; Bnt162b2 (2nd dose), for Covid-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "His arm was extremely sore after booster".  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: This is a spontaneous report received from a contactable consumer or other non-HCP. A patient (no qualifiers provided) received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient had an unexpected therapeutic response (unspecified beneficial effect of the vaccine), with outcome of unknown. Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Overdose, Palpitations
Clinical narrative: my brother had received a full non diluted dose; full arm is numb he can't even pickup a spray bottle and spray it; bad heart palpitation; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "He never smoked" (unspecified if ongoing), notes: He never smoked. The patient's concomitant medications were not reported. The following information was reported: OVERDOSE (non-serious), outcome "unknown", described as "my brother had received a full non diluted dose"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "full arm is numb he can't even pickup a spray bottle and spray it"; PALPITATIONS (non-serious), outcome "unknown", described as "bad heart palpitation".  Additional information: Name and telephone number: Reporter stated, "My name is  withheld (not alphabetically spelled hence not captured in tab) and my phone number is # (Further not clarified hence not captured in tab) you know what never mind, anyways I'm calling because my brother had received a full non diluted dose, so much higher, six dose bottle of the Pfizer vaccine and he is currently incarcerated in for medicine in withheld (further clarification unknown), now they did that about for like 70 something of this med(further clarification unknown), now mind you my brother called me the other day and he said that the CDC and Pfizer is saying that all these symptoms go away okay now my brothers full arm is numb he can't even pickup a spray bottle and spray it, now he is having bad heart palpitation now they received and take him to the hospital (further clarification unknown hence hospitalization not checked) and I'm just wondering like seriously what's going on, this is the reason why I will not get that vaccine, you not putting Nano bite in me which is basically turning me into living(Word not clear) so that I be susceptible to all this bio-terrorism, we are not doing this."   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Chest pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 26Aug2021 (Lot number: EW0169) at the age of 57 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "eczema" (unspecified if ongoing). There were no concomitant medications. The following information was reported: CHEST PAIN (non-serious) with onset 26Aug2021, outcome "recovered" (Sep2021), described as "Chest pain". The event "chest pain" was evaluated at the physician office visit and emergency room visit.  Additional information included: The report was related to a study or programme. The patient did not receive any additional vaccines administered on same date of the Pfizer Suspect. For the event Chest Pain, patient was not admitted to the hospital though. Prior Vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccines was None. Time the Vaccination Was Given: between 0800-0900. Expiry Date of Covid-19 Vaccine: Unknown. The patient did not receive other Products. He thought that, the chest pain started right after the vaccine and lasted few days after that. He clarified that it started immediately and continued on for about 10 days. Skin inflammation started after the second dose. He had a history of eczema and it caused him to flare up. It has improved and is under control now. It got out of control in the beginning of Nov2021. The patient Patient's Medical History (including any illness at time of vaccination): None. Family Medical History Relevant to AE(s): none. There were no relevant tests. Investigation Assessment: No.   No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Dermatitis
Clinical narrative: Skin inflammation; Eczema and it caused him to flare up; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program (159558). The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 23Sep2021 (Lot number: FE3592) at the age of 58 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Eczema" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose no: 1, Anatomical location: Right arm, lot/Batch number: EW0169), administration date: 26Aug2021, when the patient was 57 years old, for COVID-19 immunization, reaction(s): "Chest pain". The following information was reported: DERMATITIS (non-serious) with onset 23Sep2021, outcome "recovering", described as "Skin inflammation"; CONDITION AGGRAVATED (non-serious) with onset 2021, outcome "recovering", described as "Eczema and it caused him to flare up".  inflammation after the second dose. He thought the chest pain started right after the vaccine and lasted few days after that. He clarified that it started immediately and continued on for about 10 days. Skin inflammation started after the second dose. He has a history of eczema and it caused him to flare up. It has improved and is under control now. It got out of control in the beginning of Nov2021. Time the Vaccination Was Given was between 08:00-09:00. No additional vaccines were administered on same date of the pfizer suspect. No other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) were given. There were no AE(s) following prior vaccinations. There was no family medical history relevant to AE(s). there were no relevant Tests done.   No follow-up attempts are possible. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: headache; tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Feb2021 10:30 (Batch/Lot number: unknown) at the age of 73 years as dose 1, single and administered in arm left, administration date 20Mar2021 10:45 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Migraine" (unspecified if ongoing), notes: other medical history: Migraine; "hypothyroidism" (unspecified if ongoing), notes: other medical history: hypothyroidism. Concomitant medication(s) included: AIMOVIG. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache"; FATIGUE (non-serious), outcome "unknown", described as "tired". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Facility type vaccine: Pharmacy or Drug Store. Patient did not received other vaccines in 4 weeks. Patient received booster dose on 05Nov2021 at 02:15 in left arm.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Significant hair loss including eyebrows and eyelashes.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03Sep2021 10:30 (Lot number: EW0150) at the age of 48 years as dose 1, single and administered in arm left, administration date 24Sep2021 09:15 (Lot number: 30130BA) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: SYNTHROID taken for thyroiditis, start date: 2017 (ongoing). The following information was reported: ALOPECIA (non-serious) with onset 09Sep2021, outcome "not recovered", described as "Significant hair loss including eyebrows and eyelashes.". Therapeutic measures were not taken as a result of alopecia.  Additional information: The patient did not receive any other vaccine in four weeks. The patient did not had COVID prior vaccination and post vaccination, patient had not tested with covid 19. Significant hair loss including eyebrow and eyelashes soon after first and second covid vaccine it has been over a month and the hair loss, brow and lashes continues no other reason for this other than vaccine it is the only thing done differently. No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Migraine, Musculoskeletal stiffness
Clinical narrative: First dose, crippling migraines; back aches; joint pain; stiff neck; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 18Oct2021 (Lot number: FF2590) at the age of 30 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "If covid tested prior vaccination: Yes" (unspecified if ongoing), notes: If covid tested prior vaccination: Yes. There were no concomitant medications. Past drug history included: Prednisone, reaction(s): "Known allergies: Prednisone", notes: Known allergies: Prednisone.  The following information was reported: MIGRAINE (non-serious) with onset Nov2021, outcome "unknown", described as "First dose, crippling migraines"; BACK PAIN (non-serious) with onset Nov2021, outcome "unknown", described as "back aches"; ARTHRALGIA (non-serious) with onset Nov2021, outcome "unknown", described as "joint pain"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset Nov2021, outcome "unknown", described as "stiff neck". Therapeutic measures were not taken as a result of migraine, back pain, arthralgia, musculoskeletal stiffness.  Additional information: Other medical history: No. Other medications in two weeks: No. If other vaccine in four weeks: No. If covid prior vaccination: Yes. If covid tested post vaccination: No.   Follow-up attempts are completed. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Blood testosterone, Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 19 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 11May2021 16:00 (Lot number: ER8735) at the age of 19 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovered" (2021), described as "Sore arm". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: Specific relevant test for thromboembolic events with thrombocytopenia was none. Reported that 1st dose-sore arm, resolved in 2-3 days, he rarely get sick and have Very strong immune systems.  No follow-up attempts are possible. No further information is expected
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Decreased appetite, Migraine
Clinical narrative: Second dose, chills; fever; body ache; loss of appetite; migraines; joint pain; stiff neck; back aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old male patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: Ff2590) at the age of 30 years as dose 2, single for COVID-19 immunization. Relevant medical history included: "COVID-19" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Prednisone for known allergies: Prednisone. Vaccination history included: Bnt162b2 (Previous dose lot number: FF2590, dose administration date: 18Oct2021, dose number: 1, dose vaccine location: Left arm), when the patient was 30 years old, for COVID-19 immunization, reaction(s): "crippling migraines", "back aches", "joint pain", "stiff neck". The following information was reported: CHILLS (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "Second dose, chills"; PYREXIA (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "fever"; PAIN (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "body ache"; DECREASED APPETITE (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "loss of appetite"; MIGRAINE (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "migraines"; ARTHRALGIA (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "joint pain"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "stiff neck"; BACK PAIN (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "back aches". Therapeutic measures were not taken as a result of AEs.  Additional Information: Patient had no other medical history. Patient did not receive any other vaccine in four weeks nor received any other medications in two weeks. Patient had COVID prior vaccination. Patient had not COVID tested post vaccination.  Follow-up attempts are completed. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain, Pyrexia
Clinical narrative: Second dose, chills; fever; body ache; loss of appetite; migraines; joint pain; stiff neck; back aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old male patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: Ff2590) at the age of 30 years as dose 2, single for COVID-19 immunization. Relevant medical history included: "COVID-19" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Prednisone for known allergies: Prednisone. Vaccination history included: Bnt162b2 (Previous dose lot number: FF2590, dose administration date: 18Oct2021, dose number: 1, dose vaccine location: Left arm), when the patient was 30 years old, for COVID-19 immunization, reaction(s): "crippling migraines", "back aches", "joint pain", "stiff neck". The following information was reported: CHILLS (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "Second dose, chills"; PYREXIA (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "fever"; PAIN (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "body ache"; DECREASED APPETITE (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "loss of appetite"; MIGRAINE (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "migraines"; ARTHRALGIA (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "joint pain"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "stiff neck"; BACK PAIN (non-serious) with onset 09Nov2021 12:00, outcome "unknown", described as "back aches". Therapeutic measures were not taken as a result of AEs.  Additional Information: Patient had no other medical history. Patient did not receive any other vaccine in four weeks nor received any other medications in two weeks. Patient had COVID prior vaccination. Patient had not COVID tested post vaccination.  Follow-up attempts are completed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular
Clinical narrative: had a rash appear at the bends of both of my arms.; The rash started out as small red dots and then turned into a pink/red blotch; This is a spontaneous report received from contactable reporter (Consumer or other non-HCP). The reporter is the patient reporting for herself.  A 32 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 21Apr2021 (Lot number: EW0182) as dose 1, single and administered in arm left, administration date 12May2021 (Lot number: EW0172) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Prilosec, reaction(s): "known allergies: Prilosec"; Zantac, reaction(s): "known allergies: Zantac". The following information was reported: RASH (non-serious) with onset 23Apr2021, outcome "not recovered", described as "had a rash appear at the bends of both of my arms."; RASH MACULAR (non-serious) with onset 23Apr2021, outcome "not recovered", described as "The rash started out as small red dots and then turned into a pink/red blotch". The events "had a rash appear at the bends of both of my arms." and "the rash started out as small red dots and then turned into a pink/red blotch" were evaluated at the physician office visit. Therapeutic measures were taken as a result of rash, rash macular.  Additional information: Facility type vaccine was Hospital. Other vaccine in four weeks was None. Other medications in two weeks were None. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. Adverse event: A couple days after receiving her 1st vaccine, she had a rash appear at the bends of both of her arms. The rash started out as small red dots and then turned into a pink/red blotch. She was still dealing with this rash and have never had anything like this before. Adverse event start date: 07Nov2021. Adverse event start date: 23Apr2021. The patient received treatment for adverse events with OTC anti-fungal cream.  Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, SARS-CoV-2 antibody test
Clinical narrative: he has experienced Changes in his sense of taste, this being very similar to the taste of "medicine".; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2), administration date Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing); "Sinusitis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DYSGEUSIA (non-serious) with onset 2021, outcome "unknown", described as "he has experienced Changes in his sense of taste, this being very similar to the taste of "medicine"." Relevant laboratory tests and procedures are available in the appropriate section.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Losing extreme amounts of hair. Brushing hair and just running hands through hair results in too much loss.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Aug2021 16:30 (Lot number: FC3184) at the age of 67 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FC3181, Location of injection: Arm Right, Vaccine Administration Time: 04:30 PM), administration date: 08Aug2021, when the patient was 67 years old, for Covid-19 immunization. The following information was reported: ALOPECIA (non-serious) with onset 15Sep2021 09:00, outcome "not recovered", described as "Losing extreme amounts of hair. Brushing hair and just running hands through hair results in too much loss.". Therapeutic measures were not taken as a result of alopecia.  Additional information: Age group was Elderly (65+ Years), Other vaccine same date vaccine date was 29Aug2021.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, patient had not tested for COVID-19. no allergies was reported. no other medical history reported.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: U
Vaccine: COVID19
Symptoms: Malaise, Pain in extremity
Clinical narrative: feeling less than well; sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm right, administration date 22Feb2021 (Lot number: Pfizer CV) as dose 1, 0.3 ml single and administered in arm right, administration date 18Mar2021 (Lot number: Pfizer CV) as dose 2, 0.3 ml single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset 2021, outcome "recovered" (2021), described as "feeling less than well"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovered" (2021), described as "sore arm".  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Hypoacusis
Clinical narrative: has been having ear problems "1 ear feels like it is half deaf"; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 16Oct2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2, administration date: 17Sep2021, for Covid-19 Immunization. The following information was reported: HYPOACUSIS (non-serious) with onset 2021, outcome "unknown", described as "has been having ear problems "1 ear feels like it is half deaf"".  Additional information- The patient had ear problems. The patient 2nd vaccine was administered beyond the 21 day advisable limit. The patient also wanted to know where his specific vaccine was produced and was looking for the lot number.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy, COVID-19, Macule, Rash
Clinical narrative: spreading rash on both arms and both legs; tiny red dot with a darkish middle; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administration date 08Mar2021 20:00 (Lot number: ER8733) as dose 1, single and administration date 29Mar2021 18:00 (Lot number: 320308D) as dose 2, single for covid-19 immunisation. Relevant medical history included: "covid" (unspecified if ongoing), notes: If covid prior vaccination: Yes. There were no concomitant medications. The following information was reported: RASH (non-serious) with onset 30Mar2021 18:00, outcome "unknown", described as "spreading rash on both arms and both legs"; MACULE (non-serious) with onset 30Mar2021 18:00, outcome "unknown", described as "tiny red dot with a darkish middle". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rash, macule.  Additional information: Age at vaccination: 29 Years. Patient received 3rd dose of pfizer covid-19 vaccine on 01Nov2021, 10:00 AM, Lot number=EN6205, Vaccine location=Left arm for covid-19 immunisation. Adverse event: I have developed a spreading rash on both arms and both legs. They are tiny red dots with a darkish middle. They continue to spread across my body. If treatment ae: Antibiotic, Antiviral, Biopsy, Antiseptic, etc. patient was not covid tested post vaccination. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications in two weeks: None. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Follow-up attempts are completed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Chest pain, Cough, Dyspnoea
Clinical narrative: dry cough; chest pain; you have to catch your breath; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 05Nov2021 (Lot number: FF2590) at the age of 50 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), administered in arm left, administration date 05Nov2021 (Lot number: FK5127) as dos enumber unknown, single for immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose #1 in her right arm in the morning  between 08:00 am-10:00am. Lot EN6208.), administration date: 13Mar2021, when the patient was 49 years old, for COVID-19 immunization; Bnt162b2 (Dose #2 in her left arm, unknown time. Lot EP7533), administration date: 03Apr2021, when the patient was 49 years old, for COVID-19 immunization. The following information was reported: COUGH (non-serious) with onset 06Nov2021, outcome "not recovered", described as "dry cough"; CHEST PAIN (non-serious) with onset 06Nov2021, outcome "not recovered", described as "chest pain"; DYSPNOEA (non-serious) with onset 06Nov2021, outcome "not recovered", described as "you have to catch your breath". No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Feeling of body temperature change, Pain
Clinical narrative: the other son felt hot and cold; body aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 41 year-old male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 Immunization. The following information was reported: FEELING OF BODY TEMPERATURE CHANGE (non-serious), outcome "unknown", described as "the other son felt hot and cold"; PAIN (non-serious), outcome "unknown", described as "body aches".   Additional information: Caller commented that she would like to get the Pfizer covid 19 vaccine as it was the least reactionary she thought, but she wishes the Pfizer vaccine was only one vaccine. Caller lives in a rural area, did not have access to a computer and to a reliable car. Her local pharmacist did not have the staffing to administer the shots to people.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.